ASLN - ASLAN Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference | Benzinga
SAN MATEO, Calif. and SINGAPORE, Nov. 20, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage, immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, will participate in a fireside discussion at the Piper Sandler Healthcare Conference. The conference will be held from November 28 to 30, 2023, in-person at the Lotte New York Palace Hotel, in New York.
35TH Annual Piper Sandler Healthcare Conference Participation Information
Format: Fireside discussion
Presenter: Carl Firth, CEO, ASLAN Pharmaceuticals
Date: Wednesday, November 29, 2023
Time: 11:30 AM ET
A replay of the fireside discussion will ...